
Cinnamon could interact with some prescription medications, according to a new study
But how much is too much cinnamon? Could there be negative impacts from overconsumption of cinnamon products? People should be cautious because cinnamon could affect the metabolism of prescription drugs, according to a study published in the journal Food Chemistry: Molecular Sciences. The authors warned against overconsumption of cinnamon-containing substances, especially in individuals with other health conditions.
To help us make sense of the study findings and what the major takeaways are for cinnamon consumption, I spoke with CNN wellness expert Dr. Leana Wen, an emergency physician and adjunct associate professor at George Washington University. She previously served as Baltimore's health commissioner.
CNN: What is cinnamon — where does it come from and what are its potentially beneficial health effects?
Dr. Leana Wen: Cinnamon is a spice that comes the dried bark of Cinnamomum trees. The most common type of cinnamon sold in North America is Cassia cinnamon from the Cinnamomum aromaticum trees, according to the National Center for Complementary and Integrative Health, which is one of the centers under the National Institutes of Health. Ceylon cinnamon, sometimes called 'true' cinnamon, is from Cinnamomum verum trees.
Though some studies have suggested that cinnamon supplementation could be helpful for diabetes treatment or for weight loss, more research is needed to investigate the benefits.
Similarly, though preliminary research points to a possible role of nasal spray with Ceylon cinnamon as helping with allergic rhinitis, more research is needed to confirm that it could be a treatment.
The National Center for Complementary and Integrative Health states that 'research doesn't clearly support using cinnamon for any health condition.' Cinnamon is not approved by the US Food and Drug Administration for the treatment of any medical condition.
CNN: What is already known about possible risks of cinnamon consumption?
Wen: Cassia cinnamon may contain high levels of coumarin, which is a blood thinner. Ceylon cinnamon may also have trace amounts of coumarin. If someone who is already on anticoagulant medications ingests a large amount of coumarin, this could increase their bleeding risk.
In addition, there are known interactions between coumarin and the liver. Prolonged use of cinnamon products that have high coumarin content could pose health risks for people with liver disease. Moreover, the National Center for Complementary and Integrative Health states there are 'theoretical reasons' to think that there may be interactions between cinnamon and anticancer medications and nicotine.
CNN: What did this new study examine?
Wen: This new study examined the primary active ingredient of cinnamon, which is called cinnamaldehyde. Researchers first looked at whether cinnamaldehyde is well absorbed when orally ingested by examining gastric and intestinal fluids. They found that it is 100% bioaccessible in both fluids that are fasted and fed. That means that whether someone is fasting or has just eaten, cinnamaldehyde is expected to be well absorbed. They then discovered that cinnamaldehyde is rapidly metabolized into another compound, cinnamic acid, and that it can activate multiple receptors that affect drug metabolism.
The possible interference with drug metabolism is what led the authors to conclude that overconsumption could induce herb-drug interactions. They urge additional research looking into these possible interactions. Until those studies are complete, as the researchers indicated in an associated news release, they recommend that people looking to take cinnamon as a dietary supplement exercise caution and consult a physician before using.
CNN: Which people should use caution?
Wen: According to the study's researchers, the list of chronic conditions that should prompt caution before trying cinnamon supplementation includes hypertension, diabetes, cancer, arthritis, asthma, obesity, HIV/AIDS and depression.
I would add to that list anyone using blood thinner medications — for example, someone who has a history of heart disease and stroke, any medications that are cleared through the liver, and other dietary supplements that may interact with cinnamon, including turmeric, ginseng and gingko biloba.
CNN: What about sprinkling cinnamon in coffee or on pancakes? Should we be worried?
Wen: The researchers are quite clear that a sprinkling of cinnamon for typical culinary use is unlikely to cause problems. What they warn against is what they refer to as 'overconsumption.' This isn't clearly defined, as their study was not set up to examine what could be too high of a level of cinnamon. What overconsumption probably refers to is using concentrated cinnamon products like cinnamon supplements over a prolonged period — for instance, taking cinnamon capsules every day for months.
Individuals who are thinking of taking cinnamon supplements should be sure to consult their health care providers to check for possible medication interactions. They should also be aware that there's no clear evidence for the benefit of cinnamon supplementation.
CNN: What else would you like for people to know before starting dietary supplements?
Wen: Consumers should know that the FDA does not regulate dietary supplements like they do prescription medications. Under current law, the FDA does not have the authority to regulate the efficacy of dietary supplements. The FDA also does not review supplements before they go to market. Instead, the agency relies on post-market surveillance to identify safety problems.
People should be cautious about taking dietary supplements. Just because something is marketed as being 'natural' doesn't mean that it is safe. Also, something that is safe in small quantities may become unsafe in large quantities. People should always mention what supplements they are taking or thinking of taking to their health care provider to assess for drug interactions.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CBS News
30 minutes ago
- CBS News
Menopause retreat helps new generation of women find relief and cope with stigmas: "We're suffering silently and that's not OK"
Monica Conn, 53, describes menopause as "hot flashes, anxiety, night sweats, irritability." Instead of continuing to suffer silently through the brutal hormonal transition that 47 million women experience annually around the world, Conn has decided to do—and say—something about it. "I want to take away an attitude that I'm looking forward to my next chapter and not that something has just ended," Conn said. She signed up for the Canyon Ranch Health Spa's M/Power program, a four-day holistic menopause retreat in the Massachusetts Berkshires that promises relief, education and counseling. The Centers for Disease Control and Prevention defines menopause as "when menstrual periods stop permanently for at least 12 months," and common symptoms echo Conn's description: hot flashes, trouble sleeping, mood swings and memory problems, to name a few. M/Power's menopause and perimenopause retreats offer respite and resolve from symptoms through activities like yoga, weight training, cold plunges and more. For a long time, women have been suffering in silence about the impact symptoms have on their daily lives. "I'm learning here at Canyon Ranch that I don't know how much training our doctors even get," Conn said, adding, "the mental health component of it, how to address that, how healthy, basic foods can help you get through the day and how they affect your metabolism and your anxiety." Another aspect of the M/Power retreat is medical diagnosis, which includes blood work, hormone panels, and a DEXA body scan, which can assess things like fat composition and bone density. Dr. Jennifer Baker-Porazinski explained that a lack of estrogen, which plummets in women during menopause, causes bone density to drop—putting them at higher risk for broken bones. She says that women lose around 2% of their bone density each year for around 10 to 12 years after starting menopause. Another option for women hoping to curb symptoms is hormone therapy (HRT) but some fear it because of preliminary findings that connected HRT to increased risk of breast cancer, though critics later found flaws in the research. "Hormone therapy is the most effective treatment for the symptoms of menopause," said Dr. Sharon Malone, chief medical advisor for the women's telehealth platform "Alloy" and author of "Grown Woman Talk." Most doctors recommend taking hormones before turning 60, or within 10 years of starting menopause. For former TV journalist Tamsen Fadal, managing menopause is about community. She said she began experiencing her symptoms live on-air, and felt isolated, so she wrote the book "How to Menopause." It is essentially a "how-to" guide for women beginning the process of perimenopause or menopause. "I think this Gen X really kinda kicked the door down and said, 'hey, we're suffering silently and that's not OK.' There has to be some type of solution," Fadal said.


Health Line
an hour ago
- Health Line
Brisk Walking May Help You Live Longer, Lower Cardiovascular Disease Risk
A new study finds that short bouts of daily brisk walking are linked to a significantly lower risk of death. The research underscores the importance of intensity, not just duration, during daily physical activity. The study is the first to observe these health benefits in low-income, predominantly Black communities. Walking briskly for just 15 minutes a day is linked to a significantly lower risk of death than walking slowly, even for a much longer time. A new study, published on July 29 in the American Journal of Preventive Medicine, indicates that a faster walking pace, not just duration, may yield notable health benefits. The findings may have important implications for underserved communities. It's the first study to examine the health effects of walking pace in predominantly low-income and Black communities. The researchers said these communities often face economic barriers and are more likely to live in impoverished areas with little access to safe walking spaces. Wei Zheng, MD, PhD, MPH, the study's senior author and director of the Vanderbilt Epidemiology Center, told Healthline that the link between brisk daily walking and lower mortality risk isn't surprising. What's notable, he said, is that the benefit remains strong in communities that are typically underrepresented in research. Most previous studies have focused on white, middle- and upper-income populations. Short bouts of brisk walking could offer an accessible way for people in underserved communities to improve their health — it's low-cost, easy to do, and time-efficient. Zheng added that many people in these communities may not be able to afford a gym membership or may have a limited amount of leisure time for physical activity. 'If they can do some intensive walking, it will have a beneficial effect. One of the reasons we looked at it is because, regardless of age and fitness level, it's something most people can do,' Zheng said. Fast walking linked to 20% lower risk of death Zheng and his team examined the relationship between walking pace and death rates in 85,000 people enrolled in the Southern Community Cohort Study. Most participants were low-income and Black, recruited from 12 southeastern U.S. states. About half of them reported earning less than $15,000 per year. Participants self-reported lifestyle factors such as diet, smoking, alcohol use, and daily physical activity. Walking pace and duration were reported separately from other leisure-time physical activities. They were asked to estimate how many minutes per day they spent 'walking slowly' (for example, moving around the house or walking the dog) or 'walking fast' (such as climbing stairs or walking briskly). Over a 17-year follow-up period, 26,862 participants in the cohort died. When researchers compared reported walking patterns with mortality, they found that those who walked briskly for at least 15 minutes a day had nearly a 20% lower risk of death. Slow walking offered a modest benefit — a 4% reduction in mortality risk — but it required a significantly longer duration: more than three hours per day. The protective effect of walking was more strongly associated with a reduced number of deaths from cardiovascular disease compared to deaths from cancer. People with preexisting conditions — such as obesity or diabetes — saw even greater reductions in risk than healthier participants. 'This study puts further emphasis on fast-paced walking as a viable strategy to address existing health disparities and lower the risk of cardiovascular disease, particularly in low-income and Black populations, which see disproportionate rates of heart disease,' said Lu Qi, MD, PhD, HCA Regents Distinguished Chair and professor of epidemiology in the Celia Scott Weatherhead School of Public Health and Tropical Medicine at Tulane University. Qi wasn't involved in the research. How to pick up the pace Current guidelines recommend that adults get at least 150 minutes of moderate-intensity physical activity per week. Brisk walking, as long as the pace is vigorous enough, can help you meet that goal. Walking the dog or taking a leisurely stroll may not be enough to reach the moderate-intensity threshold. In recent years, both the medical and fitness communities have shown growing interest in the health benefits of higher-intensity exercise. In the gym, this might include HIIT workouts, while walking can be intensified with techniques like interval walking or 'Japanese walking.' 'While any activity is good, higher-quality activity can really pack a more powerful punch,' said Sarah F. Eby, MD, PhD, a sports medicine specialist at Mass General Brigham Sports Medicine and assistant professor of physical medicine and rehabilitation at Harvard Medical School. Workout intensity is subjective, but the goal of interval training is simple and widely applicable: alternate periods of higher intensity with periods of lower intensity. During a walk, this could mean switching between a slower pace and a brisk one, using your breathing as a guide to intensity. Zheng encourages everyone to 'be mindful' of their pace when they are out walking to ensure they are getting a little extra intensity. 'We walk all the time from one place to another. Increasing our pace and walking briskly during those periods not only saves time but it also offers these health benefits,' he said. However, even though walking is generally accessible, there may still be accessibility issues for some. 'The barriers to entry aren't zero. Unfortunately, folks with lower income levels tend to have less flexibility with work schedules and often live in more polluted areas that lack adequate, safe, walking infrastructure,' said Eby. She points out that there may still be opportunities for safe walking environments through participation in walking clubs or local community centers. Eby said she's even had patients tell her about doing laps in their own homes by planning indoor walking paths. 'The significant mortality benefit from regular walking demonstrated by this study highlights the need for investment in safe walkable infrastructure and considerations for workplace interventions to allow for brisk walking breaks, if even for just 15 minutes a day,' she said.
Yahoo
an hour ago
- Yahoo
Boston Scientific Stock Outlook: Is Wall Street Bullish or Bearish?
Boston Scientific Corporation (BSX), headquartered in Marlborough, Massachusetts, develops, manufactures, and markets medical devices for use in various interventional medical specialties globally. With a market cap of $157.9 billion, the company's products are used in interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, and more. Shares of this medTech giant have outperformed the broader market over the past year. BSX has gained 41.7% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 16.6%. In 2025, BSX stock is up 17.5%, surpassing the SPX's 7.8% rise on a YTD basis. More News from Barchart With UnitedHealth Under DOJ Investigation, Should You Buy, Sell, or Hold UNH Stock Now? Trump Won't Take Away Tesla's Subsidies. Does That Make TSLA Stock a Safe Buy Here? Can AMD Stock Hit $210 in 2025? Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! Zooming in further, BSX's outperformance is also apparent compared to the iShares U.S. Medical Devices ETF (IHI). The exchange-traded fund has gained about 9% over the past year. Moreover, BSX's double-digit gains on a YTD basis outshine the ETF's 2.3% gains over the same time frame. BSX's strong performance can be credited to its robust product portfolio and dedicated global team. Key achievements in the second quarter include FDA approval for expanding the FARAPULSE PFA System, initiation of the ReMATCH IDE trial, and securing CE Mark for the WATCHMAN FLX Pro device in Europe. The company also finalized the acquisitions of Intera Oncology and SoniVie, enhancing its offerings in liver cancer and hypertension treatment technologies. On Jul. 23, BSX shares closed up more than 4% after reporting its Q2 results. Its adjusted EPS of $0.75 beat Wall Street's expectations of $0.72. The company's revenue was $5.1 billion, exceeding Wall Street forecasts of $4.9 billion. The company expects full-year adjusted EPS in the range of $2.95 to $2.99. For the current fiscal year, ending in December, analysts expect BSX's EPS to grow 18.7% to $2.98 on a diluted basis. The company's earnings surprise history is impressive. It beat the consensus estimate in each of the last four quarters. Among the 30 analysts covering BSX stock, the consensus is a 'Strong Buy.' That's based on 27 'Strong Buy' ratings, two 'Moderate Buys,' and one 'Hold.' This configuration is more bullish than two months ago, with 26 analysts suggesting a 'Strong Buy.' On Jul. 24, Raymond James Financial, Inc. (RJF) analyst Jayson Bedford maintained a 'Buy' rating on BSX with a price target of $124, implying a potential upside of 18.2% from current levels. The mean price target of $124.53 represents an 18.7% premium to BSX's current price levels. The Street-high price target of $140 suggests an ambitious upside potential of 33.4%. On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on